Anavex Life Sciences Corp (AVXL)

[nidan7500]

Steady T

The inflection point is likely to be the pediatric Rett study.

That does two important things. It should show safety in children which demonstrates safety in all age groups. That opens up Rett, Fragile X, Autism, etc. at the earliest diagnosis.

Agree. Have long said that the RSD kids should/will respond more quickly to treatment, (after all these kids went from normal to RSD in a matters of a few months.) compared to PD where symptoms take many years to fully develop. My simple thinking is, these little girls will lead the way. Our MOA is WAY upstream (10+years) for the PD subjects. Nothing scientific just common sense.